Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic for non-infectious intermediate uveitis
2009-009998-10Phase 3Completed
- Sponsor
- Centre for Ophthalmology, University of Tuebingen
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in uveitis comparing Myfortic plus low-dose corticosteroids with Low-dose corticosteroid monotherapy (2 arms). Primary endpoint: Time from study entry to first relapse. Started Dec 2009; status: completed.
02
Drugs
mycophenolate sodiumprednisolone
03
Conditions
uveitis
Beyond the preview
Go deeper on 2009-009998-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009998-10.